ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
125.924,19
-1,12%
S&P 500
5.018,39
-0,34%
US Dollar vs BRL
5,1959
0,01%
Bitcoin
58.420,42
-3,60%
Brent Oil
83,54
-2,74%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NYSE
  6. Charles River Laboratories International Inc (CRL)

  7. Charles River Laboratories International Inc (CRL) Notícias

CRL Charles River Laboratories International Inc

232,69
3,69 (1,61%)
Após o horário de negociação
Última atualização: 19:43:21
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Charles River Laboratories International Inc CRL NYSE Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
3,69 1,61% 232,69 19:43:21
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
229,80 226,44 237,62 232,69 229,00
mais cotações »

Notícias Recentes

Data Hora Fonte Título
22/04/202409:00BWCharles River Laboratories Achieves 100% Renewable..
16/04/202409:00BWCharles River Laboratories Launches Alternative Methods..
12/04/202409:00BWCharles River Laboratories Schedules First-Quarter 2024..
11/04/202409:00BWCharles River and Deciphex Launch Patholytix Foresight, a..
09/04/202409:00BWCharles River Announces Rare Disease Gene Therapy..
04/04/202409:00BWCharles River to Perform Plasmid Production for Ship of..
01/04/202409:00BWCharles River Laboratories Showcases Technology-Driven..
27/03/202409:00BWCharles River Laboratories Publishes 2023 Corporate..
21/03/202409:00BWCharles River Announces Extension of Gene Therapy..
14/03/202409:00BWCharles River and Navega Therapeutics Announce Comprehensive..
12/03/202409:00BWCharles River Laboratories to Present at Barclays Global..
29/02/202404:00PRNUSWheeler Bio Seals Agreement with Charles River to Offer..
21/02/202410:00BWCharles River and Wheeler Bio Complete Agreement to..
20/02/202410:08BWCharles River Collaborates with Pluristyx, Expanding its..
14/02/202409:00BWCharles River Laboratories Announces Fourth Quarter and..
29/01/202410:00BWCharles River Introduces the First Rapid Animal-Free..
24/01/202418:30BWCharles River Laboratories Adds Reshema Kemps-Polanco to..
23/01/202418:30BWCharles River Laboratories Schedules Fourth-Quarter 2023..
16/01/202410:00BWCharles River Launches Rep/Cap Plasmids to Streamline..
08/01/202410:00BWCharles River Laboratories to Present at J.P. Morgan..
18/12/202310:00BWCharles River and Vertex Pharmaceuticals Reach Important..
12/12/202310:00BWCharles River Finalizes Agreement with CELLphenomics,..
28/11/202310:00BWCharles River and Genetic Cures for Kids Announce Gene..
27/11/202310:30BWCharles River Laboratories to Present at Evercore ISI..
16/11/202310:00BWCharles River Introduces CliniPrime Cryopreserved Leukopaks,..
13/11/202311:04PRNUSCharles River and Aitia Enter Strategic Agreement to Utilize..
13/11/202311:00BWCharles River and Aitia Enter Strategic Agreement to Utilize..
09/11/202310:00BWCharles River Laboratories’ Industry Experts to Present..
08/11/202309:00BWCharles River Laboratories Announces Third-Quarter 2023..
19/10/202309:00BWCharles River Launches Real-Time Research Model Ordering,..
16/10/202309:30BWCharles River Laboratories Schedules Third-Quarter 2023..
16/10/202309:00BWCharles River Laboratories Provides Access to Relevant,..
11/10/202309:00BWCharles River Laboratories Achieves 90% Renewable..
26/09/202309:00BWCharles River Unveils Lentivation Platform to Expedite..
25/09/202309:00BWCharles River Announces Opening of RightSourceSM Laboratory,..
20/09/202309:30BWCharles River Laboratories to Host Virtual Investor Day
14/09/202309:00BWCharles River and Related Sciences Enter Multi-Program..
11/09/202309:00BWCharles River Laboratories to Present at Baird and Morgan..
06/09/202309:00BWCharles River and PathoQuest Announce Publication of a..
24/08/202309:00BWCharles River Laboratories Announces Plasmid Manufacturing..
09/08/202308:00BWCharles River Laboratories Announces Second-Quarter 2023..
01/08/202309:00BWCharles River Laboratories Expands Access to..
19/07/202309:00BWCharles River Laboratories Schedules Second-Quarter 2023..
14/07/202306:45PRNUSCRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River..
12/07/202323:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..
12/07/202306:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
07/07/202306:45PRNUSCRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River..
06/07/202306:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
30/06/202306:45PRNUSCRL SHAREHOLDER ALERT: Jakubowitz Law Reminds Charles River..
28/06/202323:50PRNUSFILING DEADLINE--Kuznicki Law PLLC Announces Class Action on..

Seu Histórico Recente

NYSE
CRL
Charles River Laboratories
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados